Skip to main content

Table 2 Parameters of CT, FDG PET/CT, and 4DST PET/CT

From: 18F-FDG and 11C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study

Modality Parameter Baseline (n = 22) Baseline (n = 18) Interim CT or PET (n = 18) p value
CT Sum of uni-dimensional measurements of target lesion (cm) 71.9 ± 33.7 71.5 ± 28.7 61.5 ± 28.7 0.24
FDG Highest SUVmax 12.8 ± 5.0 13.7 ± 5.0 11.1 ± 7.0 0.36
Sum of SUVmax 35.2 ± 33.4 40.5 ± 34.8 29.0 ± 29.9 0.29
MTV 101.6 ± 106.3 115.0 ± 112.5 77.7 ± 87.6 0.35
TLG 618.1 ± 787.8 717.7 ± 838.4 408.1 ± 517.9 0.26
SUL 8.9 ± 4.3 9.5 ± 4.4 7.5 ± 4.4 0.14
Mean SUL of liver 1.8 ± 0.3 1.8 ± 0.3 2.0 ± 0.3 0.38
SD of mean SUL of liver 0.2 ± 0.05 0.2 ± 0.05 0.2 ± 0.03 0.16
4DST Highest SUVmax 6.6 ± 2.6 6.1 ± 2.6 6.0 ± 2.7 0.73
Sum of SUVmax 19.6 ± 16.6 20.9 ± 17.8 19.7 ± 20.0 0.38
MTV 145.9 ± 268.5 161.9 ± 286.3 80.6 ± 86.1 0.33
TLP 507.6 ± 1107.3 553.9 ± 1187.1 232.6 ± 235.5 0.42
  1. MTV metabolic tumor volume, TLG total lesion glycolysis, SUL lean body mass, TLP total lesion proliferation